Tony has over 20 years of biotech R&D experience in building out drug pipelines, and he has played a key role in developing and successfully advancing 3 new drug modalities towards the market (RNAi, modified mRNA, single domain antibodies) and in helping build several multi-billion dollar companies from start-up stage. Prior to joining Evox, Tony … Read more
Dr. Per Lundin is Co-Founder & Chief Business Officer of Evox Therapeutics Ltd. He has ~15 years’ experience founding, leading and advising biotech companies developing advanced therapies. Prior to co-founding and building out Evox, he founded and led IsletOne Therapeutics, a cell therapy company developing allogeneic cell therapies for autoimmune and inflammatory diseases, and ultimately … Read more
Kerry is a strategic and commercially-focused leader with significant experience in business change and transformation. Motivated by a passion to drive the culture and ethos of a company, as Head of HR at Centrica Customer Services she enabled the organisation to effectively engage with both their employees and with key audiences. With the ability to influence … Read more
Dave is Head of Research at Evox Therapeutics. He has over 20 years’ experience working on pioneering, multidisciplinary applied research projects. Prior to joining Evox, he led an exciting research team that focused on extracellular vesicles as a Professor at Oxford Brookes University where he secured over £1m in grant funding and published more than … Read more
Andrew is Head of CMC at Evox Therapeutics. He brings over 15 years of development experience in biologic-based drug modalities. His high-performance leadership is complemented by his expertise in all aspects of CMC including process development, vector and cell line design, and analytical and formulation development. This has aided the development and manufacture of exosome … Read more
Rupert is Head of Translational Medicine at Evox Therapeutics. He is an accomplished leader with 14 years’ experience in the field of translational science. He began his career by exploring the functional impact of T-follicular help cells and co-stimulatory mechanisms in Type 1 Diabetes and Primary Immunodeficiency Disease. Rupert subsequently led translational teams at Immunocore … Read more
Matthew is Senior Director of Operations at Evox Therapeutics. He has over 25 years’ experience in building Quality and Operations related capabilities, with particular expertise in Advanced Therapies-based biopharma drug development. Matthew has further experience in manufacturing, analytics and release from early-stage biotechnology start up through to clinical trials and commercial scale cell and gene … Read more
Bob is Senior Finance Director at Evox Therapeutics. With over 16 years’ financial experience, including a decade in the UK biotech sector, Bob is an established finance leader. He has played a pivotal role at Evox since joining in 2018, driving finance to support the company’s strategy. Before joining Evox, Bob worked at Circassia Pharmaceuticals … Read more